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PSA Screening at 
Central Maine Medical 





 PSA screening to detect early asymptomatic prostate cancer is a 
controversial practice. While screening has been shown to 
increase detection years earlier than symptoms develop, a 
mortality benefit has been harder to show. The practice also leads 
to many false positive results and unnecessary biopsies.
 Both the USPSTF and American Urological Association currently 
recommend the choice to screen in average risk individuals be 
based off the personal values and goals of the patient. 
 This is a complicated decision to make as a patient and a difficult 
conversation to facilitate for the doctor because there is good 
evidence for and against the practice.
Public Health 
Cost
 Prostate Cancer is the most common cancer that affects men and 
is the second leading cause of cancer death in men.
 PSA-based screening programs in men ages 55 to 69 years may 
prevent up to 1 to 2 deaths from prostate cancer over 
approximately 13 years per 1,000 men screened. Screening 
programs may also prevent up to 3 cases of metastatic prostate 
cancer per 1,000 men screened over 13 years.
 Follow-up of large randomized trials suggests that 20% to 50% of 
men diagnosed with prostate cancer through screening may be 




 Dr. Jordan Kurta, a Urologist at CMMC, believes that PSA 
screening is an effective tool to help assess prostate cancer risk 
but acknowledges that different physicians use this tool 
differently.
 Family Medicine Physicians at CMMC currently use the AUA and 
USPSTF recommendations to discuss PSA screening with their 
patients and initiate screening based on these conversations.
 Given the recent changes in recommendations from the USPSTF 





 A short, easy to read handout that patients can use to help them 
understand the risks and benefits of choosing to screen covering 
the following topics
 Personal risk factors
 Potential side effects of treatment
 Risk of false positives and unnecessary treatment
Results/Respo
nse
 A take-home handout for patients to review the risks and benefits 
of PSA screening and how their own personal values effect the 
choice to screen.
 Refresher handout of the USPSTF and AUA’s most recent 





 Handout allows patient’s to digest the information at their own 
pace.
 Educating patient’s ahead of time to decrease the time providers 
must spend on education of a complicated topic during the office 
visit.





 Recommendations change constantly as new evidence emerges 
and new clinical tools are found and evaluated. Patient education 
materials will have to change with new understanding of prostate 
cancer screening.
 Assess efficacy of handout by Family Physicians. Does the 
information help patient’s feel comfortable in their decision or 
generate more questions and anxiety around making and living 
with a choice?
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